Triazoles as Kv3 inhibitors
US9422252B2 · kind B2 · utility
3Cited by
8References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 22, 2013 |
| Grant date | Aug 23, 2016 |
| Priority date | — |
| Expiry date | May 22, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/02
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds of formula (I) are of use in the modulation of Kv3.1, Kv.3.2 and Kv3.3 channels and have utility in the treatment or prevention of related disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.